论文部分内容阅读
本文总结了静脉滴注普鲁卡因酰胺治疗26例心房纤颤(AF)患者的转律效果。患者男性22例,女性4例,年龄37-84岁。其中缺血性心脏病12例,瓣膜病6例,高血压性心脏病4例,充血性心肌病4例,心包炎1例,4例有两种心脏病并存,3例无原发性心脏病。22例用M型超声心动图测量了左房大小。普鲁卡因酰胺静脉滴注的速度为15-20毫克/分,最大用药量为1000毫克。若心律转为正常窦性心律或出现以下情况应停止滴注:低血压,高度房室传导阻滞、室内传导阻
This article summarizes the effect of intravenous infusion of procainamide on 26 patients with atrial fibrillation (AF). There were 22 males and 4 females, aged 37-84 years old. Including ischemic heart disease in 12 cases, valvular disease in 6 cases, 4 cases of hypertensive heart disease, congestive cardiomyopathy in 4 cases, pericarditis in 1 case, 4 cases of two kinds of heart disease coexist, 3 cases without primary heart disease. Twenty-two patients measured left atrial size using M-mode echocardiography. Procaine amide intravenous infusion rate of 15-20 mg / min, the maximum dosage of 1000 mg. If the rhythm to normal sinus rhythm or the following should stop drip: hypotension, atrioventricular block, conduction resistance